Published in JAMA on August 12, 1998
Longitudinal community plasma HIV-1 RNA concentrations and incidence of HIV-1 among injecting drug users: prospective cohort study. BMJ (2009) 6.03
Antiretroviral therapy adherence and viral suppression in HIV-infected drug users: comparison of self-report and electronic monitoring. Clin Infect Dis (2001) 5.43
Impact of active drug use on antiretroviral therapy adherence and viral suppression in HIV-infected drug users. J Gen Intern Med (2002) 5.30
Loss to follow-up of adults in public HIV care systems in central Mozambique: identifying obstacles to treatment. J Acquir Immune Defic Syndr (2009) 4.20
Improved survival among HIV-infected patients after initiation of triple-drug antiretroviral regimens. CMAJ (1999) 3.35
Adherence and plasma HIV RNA responses to highly active antiretroviral therapy among HIV-1 infected injection drug users. CMAJ (2003) 3.19
Social determinants and the health of drug users: socioeconomic status, homelessness, and incarceration. Public Health Rep (2002) 3.14
Methadone maintenance therapy promotes initiation of antiretroviral therapy among injection drug users. Addiction (2010) 2.65
Superiority of directly administered antiretroviral therapy over self-administered therapy among HIV-infected drug users: a prospective, randomized, controlled trial. Clin Infect Dis (2007) 2.37
Social and environmental predictors of plasma HIV RNA rebound among injection drug users treated with antiretroviral therapy. J Acquir Immune Defic Syndr (2012) 1.80
The problem of late ART initiation in Sub-Saharan Africa: a transient aspect of scale-up or a long-term phenomenon? J Health Care Poor Underserved (2013) 1.75
Effects of drug abuse and mental disorders on use and type of antiretroviral therapy in HIV-infected persons. J Gen Intern Med (2001) 1.73
Integration and co-location of HIV/AIDS, tuberculosis and drug treatment services. Int J Drug Policy (2007) 1.65
Use of antiretroviral therapies among HIV-infected men who have sex with men: a household-based sample of 4 major American cities. Am J Public Health (2001) 1.63
Factors associated with premature mortality among young injection drug users in Vancouver. Harm Reduct J (2007) 1.60
Delays in protease inhibitor use in clinical practice. J Gen Intern Med (1999) 1.54
Late HIV diagnosis and determinants of progression to AIDS or death after HIV diagnosis among injection drug users, 33 US States, 1996-2004. PLoS One (2009) 1.48
Disparities in HIV treatment and physician attitudes about delaying protease inhibitors for nonadherent patients. J Gen Intern Med (2004) 1.47
Reason and rights in global drug control policy. CMAJ (2005) 1.44
Provider and clinic-level correlates of deferring antiretroviral therapy for people who inject drugs: a survey of North American HIV providers. J Int AIDS Soc (2012) 1.44
Hepatitis C virus infection in San Francisco's HIV-infected urban poor. J Gen Intern Med (2004) 1.41
Antiretroviral treatment regimen outcomes among HIV-infected prisoners. HIV Clin Trials (2007) 1.39
Alcohol use and incarceration adversely affect HIV-1 RNA suppression among injection drug users starting antiretroviral therapy. J Urban Health (2003) 1.38
Homelessness and adherence to antiretroviral therapy among a cohort of HIV-infected injection drug users. J Urban Health (2011) 1.36
Factors associated with interest in initiating treatment for hepatitis C Virus (HCV) infection among young HCV-infected injection drug users. Clin Infect Dis (2005) 1.35
Access and utilization of HIV treatment and services among women sex workers in Vancouver's Downtown Eastside. J Urban Health (2005) 1.35
Effectiveness of highly active antiretroviral therapy among injection drug users with late-stage human immunodeficiency virus infection. Am J Epidemiol (2005) 1.34
Homelessness as a structural barrier to effective antiretroviral therapy among HIV-seropositive illicit drug users in a Canadian setting. AIDS Patient Care STDS (2011) 1.33
The prevalence of homelessness among injection drug users with and without HIV infection. J Urban Health (2000) 1.30
Persistence of virological benefits following directly administered antiretroviral therapy among drug users: results from a randomized controlled trial. J Acquir Immune Defic Syndr (2009) 1.29
Illicit drug use, depression and their association with highly active antiretroviral therapy in HIV-positive women. Drug Alcohol Depend (2007) 1.28
Optimizing care for HIV-infected people who use drugs: evidence-based approaches to overcoming healthcare disparities. Clin Infect Dis (2013) 1.24
Interaction between buprenorphine and atazanavir or atazanavir/ritonavir. Drug Alcohol Depend (2007) 1.21
Women-specific HIV/AIDS services: identifying and defining the components of holistic service delivery for women living with HIV/AIDS. J Int AIDS Soc (2013) 1.21
Female gender predicts lower access and adherence to antiretroviral therapy in a setting of free healthcare. BMC Infect Dis (2011) 1.20
Adherence and antiretroviral therapy in injection drug users. JAMA (1998) 1.19
Social and structural factors associated with HIV disease progression among illicit drug users: a systematic review. AIDS (2012) 1.18
Severe food insecurity is associated with elevated unprotected sex among HIV-seropositive injection drug users independent of HAART use. AIDS (2011) 1.17
Substance abuse, adherence with antiretroviral therapy, and clinical outcomes among HIV-infected individuals. Life Sci (2010) 1.16
Adherence to antiretroviral therapy in India: a systematic review and meta-analysis. Indian J Community Med (2013) 1.16
The pharmacokinetics of methadone in HIV-positive patients receiving the non-nucleoside reverse transcriptase inhibitor efavirenz. Br J Clin Pharmacol (2001) 1.16
Drug use and receipt of highly active antiretroviral therapy among HIV-infected persons in two U.S. clinic cohorts. PLoS One (2011) 1.10
Emergency department utilization among a cohort of HIV-positive injecting drug users in a Canadian setting. J Emerg Med (2011) 1.08
Determinants of hospital admission among HIV-positive people in British Columbia. CMAJ (2000) 1.07
Highly active antiretroviral treatment does not increase sexual risk behaviour among French HIV infected injecting drug users. J Epidemiol Community Health (2002) 1.07
Aboriginal status is a prognostic factor for mortality among antiretroviral naïve HIV-positive individuals first initiating HAART. AIDS Res Ther (2006) 1.06
Poverty, hunger, education, and residential status impact survival in HIV. AIDS Behav (2011) 1.05
Integration of health services improves multiple healthcare outcomes among HIV-infected people who inject drugs in Ukraine. Drug Alcohol Depend (2013) 1.03
Strategies to improve access to and utilization of health care services and adherence to antiretroviral therapy among HIV-infected drug users. Subst Use Misuse (2011) 1.03
The impact of methadone maintenance therapy on hepatitis C incidence among illicit drug users. Addiction (2014) 1.02
Behavior change and health-related interventions for heterosexual risk reduction among drug users. Subst Use Misuse (2006) 1.02
Substance abuse treatment in human immunodeficiency virus: the role of patient-provider discussions. J Subst Abuse Treat (2008) 1.01
Directly administered antiretroviral therapy for HIV-infected drug users does not have an impact on antiretroviral resistance: results from a randomized controlled trial. J Acquir Immune Defic Syndr (2007) 0.99
Pilot study to enhance HIV care using needle exchange-based health services for out-of-treatment injecting drug users. J Urban Health (2003) 0.98
Improved adherence to modern antiretroviral therapy among HIV-infected injecting drug users. HIV Med (2012) 0.98
Never in care: characteristics of HIV-infected crack cocaine users in 2 US cities who have never been to outpatient HIV care. J Acquir Immune Defic Syndr (2010) 0.97
High prevalence of childhood emotional, physical and sexual trauma among a Canadian cohort of HIV-seropositive illicit drug users. AIDS Care (2011) 0.96
The relationship between injection and noninjection drug use and HIV disease progression. J Subst Abuse Treat (2011) 0.96
No evidence of increased sexual risk behaviour after initiating antiretroviral therapy among people who inject drugs. AIDS (2010) 0.95
Impact of binge alcohol on mortality among people who inject drugs. Addict Behav Rep (2015) 0.95
Drug use patterns associated with risk of non-adherence to antiretroviral therapy among HIV-positive illicit drug users in a Canadian setting: a longitudinal analysis. BMC Infect Dis (2015) 0.95
Use of protease inhibitors and non-nucleoside reverse transcriptase inhibitors among Medicaid beneficiaries with AIDS. Am J Public Health (2001) 0.94
Patterns of heroin and cocaine injection and plasma HIV-1 RNA suppression among a long-term cohort of injection drug users. Drug Alcohol Depend (2012) 0.93
Suboptimal plasma HIV-1 RNA suppression and adherence among sex workers who use illicit drugs in a Canadian setting: an observational cohort study. Sex Transm Infect (2014) 0.93
Gender inequities in quality of care among HIV-positive individuals initiating antiretroviral treatment in British Columbia, Canada (2000-2010). PLoS One (2014) 0.93
Illicit drug use is a significant risk factor for loss to follow up in patients with HIV-1 infection at a large urban HIV clinic in Tokyo. PLoS One (2013) 0.93
Incarceration is associated with used syringe lending among active injection drug users with detectable plasma HIV-1 RNA: a longitudinal analysis. BMC Infect Dis (2013) 0.93
Sex-Based Differences in Rates, Causes, and Predictors of Death Among Injection Drug Users in Vancouver, Canada. Am J Epidemiol (2016) 0.92
Pathways to HIV risk and vulnerability among lesbian, gay, bisexual, and transgendered methamphetamine users: a multi-cohort gender-based analysis. BMC Public Health (2011) 0.92
The effect of prescription opioid injection on the risk of non-fatal overdose among people who inject drugs. Drug Alcohol Depend (2015) 0.90
Management of HIV infection in patients with substance use problems. Curr Infect Dis Rep (2008) 0.90
Factors associated with HIV viral load in a respondent driven sample in Los Angeles. AIDS Behav (2007) 0.90
Difficulty accessing syringes mediates the relationship between methamphetamine use and syringe sharing among young injection drug users. AIDS Behav (2011) 0.89
Physician experience and rates of plasma HIV-1 RNA suppression among illicit drug users: an observational study. BMC Infect Dis (2012) 0.89
When should we delay highly active antiretroviral therapy? J Gen Intern Med (1999) 0.89
The Demand for Antiretroviral Drugs in the Illicit Marketplace: Implications for HIV Disease Management Among Vulnerable Populations. AIDS Behav (2015) 0.88
Employment predicts decreased mortality among HIV-seropositive illicit drug users in a setting of universal HIV care. J Epidemiol Community Health (2013) 0.88
The Impact of Enrolment in Methadone Maintenance Therapy on Initiation of Heavy Drinking among People Who Use Heroin. Eur Addict Res (2016) 0.88
Sticking to it: the effect of maximally assisted therapy on antiretroviral treatment adherence among individuals living with HIV who are unstably housed. AIDS Behav (2011) 0.87
Increases in the availability of prescribed opioids in a Canadian setting. Drug Alcohol Depend (2012) 0.87
High prevalence of illicit drug use in men who have sex with men with HIV-1 infection in Japan. PLoS One (2013) 0.86
The impact of drug use patterns on mortality among polysubstance users in a Canadian setting: a prospective cohort study. BMC Public Health (2014) 0.86
Highly active antiretroviral therapy and hospital readmission: comparison of a matched cohort. BMC Infect Dis (2006) 0.86
Medical consequences of drug abuse and co-occurring infections: research at the National Institute on Drug Abuse. Subst Abus (2008) 0.85
Impact of unstable housing on all-cause mortality among persons who inject drugs. BMC Public Health (2015) 0.85
Overview of HIV among injection drug users in New York City: critical next steps to eliminate racial/ethnic disparities. Subst Use Misuse (2011) 0.84
Injection drug use and HIV antiretroviral therapy discontinuation in a Canadian setting. AIDS Behav (2013) 0.84
Mechanism(s) involved in opioid drug abuse modulation of HAND. Curr HIV Res (2012) 0.83
Pain Among High-Risk Patients on Methadone Maintenance Treatment. J Pain (2015) 0.82
Crystal methamphetamine injection predicts slower HIV RNA suppression among injection drug users. Addict Behav (2011) 0.82
High-intensity cannabis use associated with lower plasma human immunodeficiency virus-1 RNA viral load among recently infected people who use injection drugs. Drug Alcohol Rev (2014) 0.82
The validity of reporting willingness to use a supervised injecting facility on subsequent program use among people who use injection drugs. Am J Drug Alcohol Abuse (2011) 0.82
Ongoing impact of HIV infection on mortality among people who inject drugs despite free antiretroviral therapy. Addiction (2014) 0.81
Rates of inappropriate antiretroviral prescription among injection drug users. Harm Reduct J (2007) 0.81
Increased Prevalence of Controlled Viremia and Decreased Rates of HIV Drug Resistance Among HIV-Positive People Who Use Illicit Drugs During a Community-wide Treatment-as-Prevention Initiative. Clin Infect Dis (2015) 0.80
Correlates of antiretroviral utilization among hospitalized HIV-infected crack cocaine users. AIDS Res Hum Retroviruses (2012) 0.80
Factors associated with optimal pharmacy refill adherence for antiretroviral medications and plasma HIV RNA non-detectability among HIV-positive crack cocaine users: a prospective cohort study. BMC Infect Dis (2016) 0.79
HIV infection among people who inject drugs: the challenge of racial/ethnic disparities. Am Psychol (2013) 0.78
Personalized therapeutics: a potential threat to health equity. J Gen Intern Med (2012) 0.78
Factors linked to transitions in adherence to antiretroviral therapy among HIV-infected illicit drug users in a Canadian setting. AIDS Care (2015) 0.78
Needle exchange is not enough: lessons from the Vancouver injecting drug use study. AIDS (1997) 9.08
Rates of disease progression by baseline CD4 cell count and viral load after initiating triple-drug therapy. JAMA (2001) 7.63
Improved survival among HIV-infected individuals following initiation of antiretroviral therapy. JAMA (1998) 6.69
Antiretroviral therapy in adults: updated recommendations of the International AIDS Society-USA Panel. JAMA (2000) 6.49
Antiretroviral therapy for HIV infection in 1997. Updated recommendations of the International AIDS Society-USA panel. JAMA (1997) 6.35
The psychological consequences of predictive testing for Huntington's disease. Canadian Collaborative Study of Predictive Testing. N Engl J Med (1992) 5.51
Antiretroviral therapy for HIV infection in 1996. Recommendations of an international panel. International AIDS Society-USA. JAMA (1996) 5.29
Unsafe injection practices in a cohort of injection drug users in Vancouver: could safer injecting rooms help? CMAJ (2001) 4.96
Antiretroviral therapy for HIV infection in 1998: updated recommendations of the International AIDS Society-USA Panel. JAMA (1998) 4.61
Relation of family responsibilities and gender to the productivity and career satisfaction of medical faculty. Ann Intern Med (1998) 4.52
Preliminary evaluation of a scheme for grading the gross morphology of the human intervertebral disc. Spine (Phila Pa 1976) (1990) 4.11
HIV-1 and the aetiology of AIDS. Lancet (1993) 3.69
Prevalence and structural correlates of gender based violence among a prospective cohort of female sex workers. BMJ (2009) 3.56
Hospital utilization and costs in a cohort of injection drug users. CMAJ (2001) 3.48
Improved survival among HIV-infected patients after initiation of triple-drug antiretroviral regimens. CMAJ (1999) 3.35
Isolation of drug-resistant variants of HIV-1 from patients on long-term zidovudine therapy. Canadian Zidovudine Multi-Centre Study Group. AIDS (1989) 3.19
Decline in deaths from AIDS due to new antiretrovirals. Lancet (1997) 3.13
Do needle exchange programmes increase the spread of HIV among injection drug users?: an investigation of the Vancouver outbreak. AIDS (1999) 3.01
Adherence to triple therapy and viral load response. J Acquir Immune Defic Syndr (2000) 2.94
Practice patterns of family physicians with 2-year residency v. 1-year internship training: do both roads lead to Rome? CMAJ (1989) 2.87
Corticosteroids prevent early deterioration in patients with moderately severe Pneumocystis carinii pneumonia and the acquired immunodeficiency syndrome (AIDS) Ann Intern Med (1990) 2.85
Impact of HIV infection on mortality in a cohort of injection drug users. J Acquir Immune Defic Syndr (2001) 2.80
Changes in sexual behaviour and fear of AIDS. Lancet (1984) 2.76
A reality check: the cost of making post-exposure prophylaxis available to gay and bisexual men at high sexual risk. AIDS (2000) 2.71
The cost of obesity in Canada. CMAJ (1999) 2.71
Lower socioeconomic status and shorter survival following HIV infection. Lancet (1994) 2.47
Incidence of hepatitis C virus infection among injection drug users during an outbreak of HIV infection. CMAJ (2001) 2.47
Industry-sponsored clinical research: a double-edged sword. Lancet (2001) 2.45
HTLV-III infection in Canada in 1985. CMAJ (1986) 2.44
Extent to which low-level use of antiretroviral treatment could curb the AIDS epidemic in sub-Saharan Africa. Lancet (2000) 2.42
The incidence and spectrum of AIDS-defining illnesses in persons treated with antiretroviral drugs. Clin Infect Dis (1998) 2.31
Spinal bone loss and ovulatory disturbances. N Engl J Med (1990) 2.31
Safe injection facilities in Canada: is it time? CMAJ (2001) 2.31
Rectal gonorrhoea as an independent risk factor for HIV infection in a cohort of homosexual men. Genitourin Med (1995) 2.22
An anonymous seroprevalence survey of HIV infection among pregnant women in British Columbia and the Yukon Territory. CMAJ (1990) 2.21
Retinopathy of prematurity-induced blindness: birth weight-specific survival and the new epidemic. Pediatrics (1990) 2.18
Multiple drug rescue therapy for HIV-infected individuals with prior virologic failure to multiple regimens. AIDS (2001) 2.15
The Vancouver Lymphadenopathy-AIDS Study: 4. Effects of exposure factors, cofactors and HTLV-III seropositivity on number of helper T cells. Can Med Assoc J (1985) 2.11
The role of secondary vaccine failures in measles outbreaks. Am J Public Health (1989) 2.10
Stability of dried blood spot specimens for detection of human immunodeficiency virus DNA by polymerase chain reaction. J Clin Microbiol (1992) 2.10
Decreasing frequency but worsening mortality of acute respiratory failure secondary to AIDS-related Pneumocystis carinii pneumonia. Chest (1994) 2.10
Social determinants predict needle-sharing behaviour among injection drug users in Vancouver, Canada. Addiction (1997) 2.06
Use of dried blood spot specimens in the detection of human immunodeficiency virus type 1 by the polymerase chain reaction. J Clin Microbiol (1991) 2.05
High exposure to nevirapine in plasma is associated with an improved virological response in HIV-1-infected individuals. AIDS (2001) 2.03
The Vancouver Lymphadenopathy-AIDS Study: 6. HIV seroconversion in a cohort of homosexual men. CMAJ (1986) 2.01
Triple-combination antiretroviral therapy in sub-Saharan Africa. Lancet (1997) 2.00
Determinants of sexual risk-taking among young HIV-negative gay and bisexual men. J Acquir Immune Defic Syndr Hum Retrovirol (1998) 1.99